COO
The Cooper Companies, Inc.
68.51
1 x 68.50
1 x 69.27
bid
ask
-
2.81
3.94%
3 @ 07:07 PM
68.56 +0.05 (0.07%)
Ytd-16.41%
1y-6.93%
68.37
day range
70.39
58.89
52 week range
89.83
Open69.90Prev Close71.32Low68.37High70.39Mkt Cap13.79B
Vol2.17MAvg Vol2.91MEPS1.18P/E59.92Forward P/E14.15
Beta0.84Short Ratio1.92Inst. Own107.16%DividendN/ADiv YieldN/A
Ex Div Date07-26Earning09-0350-d Avg64.91200-d Avg72.891yr Est81.07
Earning
DateForEstimateReportedSurprisesurprise %
2026-06-042026-041.1N/AN/AN/A
2026-03-052026-011.031.10.076.80%
2025-12-042025-101.111.150.043.60%
2025-08-272025-071.071.10.032.80%
2025-05-292025-040.930.960.033.23%
2025-03-062025-010.920.92N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2026-07-08CitigroupUpgradeNeutralNeutral
2026-06-08BNP ParibasUpgradeOutperformOutperform
2026-06-05JP MorganUpgradeNeutralNeutral
2026-06-05StifelUpgradeBuyBuy
2026-06-05Wells FargoUpgradeEqual-WeightEqual-Weight
2026-06-05NeedhamUpgradeBuyBuy
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Holder
DateNameRelationQuantityDescription
2026-01-07ANDREWS BRIAN GChief Financial Officer30.73KConversion of Exercise of derivative security
2026-03-31JAY COLLEEN EDirector39.91KConversion of Exercise of derivative security
2025-03-31KOZY WILLIAM ADirector31.15KConversion of Exercise of derivative security
2026-03-31MADDEN TERESA SMITHDirector15.68KConversion of Exercise of derivative security
2026-01-07MCBRIDE DANIEL GChief Operating Officer163.85KConversion of Exercise of derivative security
2026-03-31RIVAS MARIADirector14.46KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2025-12-30Vanguard Group Inc23.55M0.0012.08%
2026-03-30BlackRock Inc16.62M0.008.53%
2026-03-30Vanguard Capital Management, LLC12.72M0.006.53%
2026-03-30T. Rowe Price Investment Management,Inc.9.06M0.004.65%
2026-03-30State Street Corp8.77M0.004.50%
2026-03-30Vanguard Portfolio Management, LLC8.72M0.004.47%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-04-29Vanguard Total Stock Mkt Idx Inv6.21M0.003.18%
2026-04-29Vanguard 500 Index Investor5.08M0.002.61%
2026-04-29Vanguard Small Cap Index4.50M0.002.31%
2026-03-30T. Rowe Price US Mid-Cap Growth Equity4.27M0.002.19%
2026-04-29T. Rowe Price Mid-Cap Growth4.27M0.002.19%
2026-03-30American Funds New Perspective A3.61M0.001.85%
Dividend
DividendDate
0.032023-07-27
0.032023-07-26
0.032023-01-20
0.032022-07-26
0.032022-01-20
0.032021-07-26
Split
SplitDate
4 : 12024-02-20
2 : 12002-11-25
1 : 31995-09-22
110 : 1001983-09-26